Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
DOP17: AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of Inflammatory Bowel Disease (IBD)
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Mei Wang
Created: Tuesday, 28 May 2019, 3:32 PM
JAK inhibitors, Immunology, Lymphocyte, T cell
Files: 1
DOP17: Identification of biomarkers and mechanistic insight for upadacitinib in Ulcerative Colitis: Analysis of serum inflammatory mediators in the phase 2b U-ACHIEVE study
Year: 2020
Source: ECCO'20 Vienna
Authors: Séverine Vermeire
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP18: Impact of adherence to anti- tumor necrosis factor therapy on clinical outcomes in Crohn's Disease: A nationwide population-based study
Year: 2020
Source: ECCO'20 Vienna
Authors: Jae Jun Park
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP18: OSM neutralisation in IBD mucosal explant cultures reduces pro-inflammatory cytokine production
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Gillian Tannahill
Created: Tuesday, 28 May 2019, 3:32 PM
Immunology
Files: 1
DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Year: 2020
Source: ECCO'20 Vienna
Authors: Jason Rogers
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP20: Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
Year: 2020
Source: ECCO'20 Vienna
Authors: Greetje Adriaans
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP20: Drugs that modulate histone acetylation disrupt TGF-β- signalling and reduce collagen I expression in models of stricturing Crohn’s disease
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Amy Lewis
Created: Tuesday, 28 May 2019, 3:32 PM
Files: 1
DOP21: Time to first treatment with biologic agents for Ulcerative Colitis and Crohn’s Disease across four Nordic countries: Results from the TRINordic study
Year: 2020
Source: ECCO'20 Vienna
Authors: Marte Høivik
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
Year: 2020
Source: ECCO'20 Vienna
Authors: Manuel Barreiro-de Acosta
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids.
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Kohei Suzuki
Created: Tuesday, 28 May 2019, 3:32 PM
Epithelial cell
Files: 1
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Catherine Le Berre
Created: Tuesday, 28 May 2019, 3:32 PM
Ileo caecal resection, Post operative complications, Post operative medical management, Post-operative IBD, Immunology, Lymphocyte, T cell
Files: 1
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Bruce Weder
Created: Tuesday, 28 May 2019, 3:32 PM
Fibroblast, Fibrosis
Files: 1
DOP25: Medication use and comorbidities among elderly as compared to younger patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort
Year: 2020
Source: ECCO'20 Vienna
Authors: Bruce E Sands
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP25: Unraveling Vedolizumab mechanism of action in Ulcerative Colitis
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Marisol Veny
Created: Tuesday, 28 May 2019, 3:32 PM
Vedolizumab, Lymphocyte
Files: 1
DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patients
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Brecht Creyns
Created: Tuesday, 28 May 2019, 3:32 PM
Immunology, Innate lymphoid cell, Lymphocyte
Files: 1
DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Clas-Göran Af Björkesten
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failure
Year: 2020
Source: ECCO'20 Vienna
Authors: Elise Van Praag
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP28: Maternal obstetric outcomes in women with IBD compared to the general population
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Gillian Lever
Created: Tuesday, 28 May 2019, 3:32 PM
IBD in pregnancy
Files: 1
DOP28: Understanding the molecular mechanisms of anti-TNF treatment failure in patients with Crohn’s Disease: A pilot serum proteomic analysis of the PANTS cohort
Year: 2020
Source: ECCO'20 Vienna
Authors: Simeng Lin
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP30: Factors associated with life satisfaction in people with Crohn's Disease and Ulcerative Colitis: results from the national 2018 Crohn's and Colitis UK Inflammatory Bowel Disease Quality of Life Survey
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Georgina Rowse
Created: Tuesday, 28 May 2019, 3:32 PM
Crohn’s disease, Ulcerative colitis, Quality of life (IBDQ), Psychological co-morbidity, Psychological co-morbidity, Coping
Files: 1